Qingdao NovelBeam Technology Co.,Ltd. Stock

Equities

688677

CNE100005410

Advanced Medical Equipment & Technology

End-of-day quote Shanghai S.E. 06:00:00 2024-05-07 pm EDT 5-day change 1st Jan Change
47.25 CNY +2.58% Intraday chart for Qingdao NovelBeam Technology Co.,Ltd. +5.52% -11.23%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
Sales 2024 * 607M 84.08M Sales 2025 * 817M 113M Capitalization 5.69B 788M
Net income 2024 * 206M 28.51M Net income 2025 * 281M 38.89M EV / Sales 2024 * 9.37 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 6.96 x
P/E ratio 2024 *
27.9 x
P/E ratio 2025 *
20.5 x
Employees 854
Yield 2024 *
1.27%
Yield 2025 *
1.9%
Free-Float 56.21%
More Fundamentals * Assessed data
Dynamic Chart
Qingdao NovelBeam Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Tranche Update on Qingdao NovelBeam Technology Co.,Ltd.'s Equity Buyback Plan announced on June 16, 2023. CI
Qingdao NovelBeam Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Tranche Update on Qingdao NovelBeam Technology Co.,Ltd.'s Equity Buyback Plan announced on June 16, 2023. CI
Qingdao NovelBeam Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Tranche Update on Qingdao NovelBeam Technology Co.,Ltd.'s Equity Buyback Plan announced on June 16, 2023. CI
Qingdao NovelBeam Technology Co.,Ltd.(XSSC:688677) added to S&P Global BMI Index CI
Qingdao NovelBeam Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Tranche Update on Qingdao NovelBeam Technology Co.,Ltd.'s Equity Buyback Plan announced on June 16, 2023. CI
Qingdao NovelBeam Technology Co.,Ltd. announces an Equity Buyback for CNY 60 million worth of its shares. CI
Qingdao NovelBeam Technology Co.,Ltd. authorizes a Buyback Plan. CI
Qingdao NovelBeam Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Tranche Update on Qingdao NovelBeam Technology Co.,Ltd.'s Equity Buyback Plan announced on April 1, 2022. CI
Qingdao NovelBeam Technology Co.,Ltd.'s Equity Buyback announced on April 1, 2022, has closed with 336,548 shares, representing 0.39% for CNY 30.11 million. CI
Qingdao NovelBeam Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
More news
1 day+2.58%
1 week+5.52%
Current month+5.52%
1 month-0.94%
3 months-15.44%
6 months-19.22%
Current year-11.23%
More quotes
1 week
45.45
Extreme 45.45
48.30
1 month
39.11
Extreme 39.11
48.97
Current year
39.11
Extreme 39.11
58.00
1 year
39.11
Extreme 39.11
75.49
3 years
39.11
Extreme 39.11
102.06
5 years
39.11
Extreme 39.11
102.06
10 years
39.11
Extreme 39.11
102.06
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 -
Director of Finance/CFO 56 04-04-30
Chairman 42 07-02-28
Members of the board TitleAgeSince
Chairman 59 -
Chief Executive Officer 50 -
Director/Board Member 60 19-12-27
More insiders
Date Price Change Volume
24-05-08 47.25 +2.58% 1,680,180
24-05-07 46.06 -2.83% 1,935,525
24-05-06 47.4 +5.85% 2,077,348
24-04-30 44.78 +0.36% 1,645,111

End-of-day quote Shanghai S.E., May 07, 2024

More quotes
Qingdao NovelBeam Technology Co Ltd is a China-based company principally engaged in the research and development, production and sales of medical endoscopic equipment and optical products. Its main products of medical endoscope equipment include fluorescent endoscopes, fluorescent camera adapters/adaptive lenses, fluorescent light source modules and white light source modules. Its medical endoscopic equipment products are mainly used in abdominal endoscopic surgery such as liver and gallbladder and gastrointestinal surgery. Its optical products mainly include medical optical products, industrial and laser optical products, and biometric products. Among them, the biometric products include fingerprint devices, palmprint devices and related accessories. In addition, the Company also provides technical services and house leasing services. The Company distributes its products both in the domestic market and to overseas markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
47.25 CNY
Average target price
59 CNY
Spread / Average Target
+24.87%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688677 Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW